Bhutan vs Laos: Cause of death, by non-communicable diseases, ages 15-59, female
Bhutan
66.5%
in 2021
Laos
66.7%
in 2021
Bhutan rank
73rd
Laos rank
71st
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Bhutan
- Laos
How they compare
Laos currently reports 66.7% against 66.5% in Bhutan, a difference of 0.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Bhutan ahead.
Bhutan ranks 73rd and Laos ranks 71st of 185 countries.
Across the 3 decades both report, Bhutan averaged higher in 1 and Laos in 2.
Head to head by decade
| Decade | Bhutan | Laos | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.0% | 47.2% | 4.8% | Bhutan |
| 2010s | 62.4% | 63.1% | 0.7% | Laos |
| 2020s | 66.6% | 69.0% | 2.4% | Laos |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Bhutan or Laos?
- Laos, at 66.7% against 66.5% in Bhutan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Bhutan and Laos?
- 0.2%, with Laos ahead.
- How many years of comparable data are there for Bhutan and Laos?
- 6 years are reported by both, from 2000 to 2021.
- How do Bhutan and Laos rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Bhutan ranks 73rd and Laos ranks 71st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.